tiprankstipranks
Trending News
More News >
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Revenue

Compare
386 Followers

Evaxion Biotech Revenue

Evaxion Biotech had a revenue of 7.49M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 7.65M, Decreased 140.90%. In the fiscal year ending Dec 31, 2024, Evaxion Biotech had annual revenue of 3.34M with 4480.82% growth.
Revenue (ttm)
7.65M
Revenue Growth
4455.07%
P/S Ratio
9.69
Revenue/Employee
$72,696
Employees
46
Market Cap
$32.40M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
3.34M3.27M+4,580.88%
Dec 31, 2023
73.00K-7,300,000.00%
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018